Lateral Flow Testing
The COVID-19 pandemic has fundamentally changed the LFA Lateral Flow market, creating new opportunities…
Perception & Use
The LFA is a mature, widely-accepted diagnostic testing technology. Their use has been ubiquitous in high, low and middle-income countries for the past 3 decades, with the pregnancy test frequent in high-income and frontline infection disease testing frequent in lower and middle-income countries.
A number of LFA applications have been developed, adopted and very successfully commercialised.
The World Health Organization has called for new LFA devices to enable wide-spread testing in resource limited settings.
The COVID-19 pandemic has shown LFAs to be effective and acceptable for mass public and personal health use.
The COVID-19 pandemic has caused a shortfall in individual access to the diagnostics they require (e.g. cancer testing).
Here at SwiftDx, our mission is to address this unmet need with sensitivity-boosting technologies, by allowing for simple and cost-effective testing at home or on a community level.